Skip to main content
. 2023 Jan 27;37(3):505–517. doi: 10.1038/s41375-023-01822-2

Table 4.

Diagnostic work-up of relapse after allogeneic HSCT.

Diagnostics
Bone Marrow

Morphology

Blast % and promyelocytes %

Flow cytometry and/or cytochemistry

Cytogenetics (for Ph-positive and/or additional chromosomal aberrations)

with a minimum of 15 metaphases analyzed

Fluorescent-in-situ-hybridization (FISH) if marrow cytogenetics fails

Molecular genetics Tyrosine kinase domain mutation analysis if BCR::ABL1 transcript level >1%
Cerebrospinal Fluid Cytology